PROXY STATEMENT

Company

Allarity Therapeutics, Inc.

Filed

March 8, 2024

Period of Report

April 1, 2024

Accession Number

0001174947-24-000304

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →